13 results
management diagnosis algorithm anticoagulation cancer doac latenttb malignancy syndrome tb tuberculosis venous anemia aplastic apml cardiomyopathy classification differentiation dvt embolism
Venous Thromboembolism Treatment Algorithm Branch points: Active bleeding? Active malignancy? Provoked? - Dr. Joseph Shatzel @Clotmaster #Management #VTE #DVT
Branch points: Active ... bleeding? ... Active malignancy ... #Management #VTE ... #Hematology #Anticoagulation
Treatment Algorithm for First Time Pulmonary Embolism • Provoked • Unprovoked • Active Malignancy By Carlin Rooke,
Treatment Algorithm ... Unprovoked • Active ... #PE #Pulmonary # ... Algorithm #management #hematology ... #VTE #thrombosis
Treatment algorithm for VTE in Malignancy (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... at high risk of bleeding ... risk of recurrent VTE ... Anticoagulation #Management #Hematology ... #Oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... thrombosis; PE = pulmonary ... body mass index; VTE ... Anticoagulation #Management #Hematology ... #Oncology
►
 Leukemias Overview: ALL, CML, AML, APML, CLL Acute leukemias > 20% blasts in the peripheral blood smear
Tyrosine Kinase activity ... night sweats, bleeding ... • Significant bleeding ... #Leukemia #Hematology ... #Oncology #Diagnosis
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... involvement - seeding ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... involvement - seeding ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Triggers: ATRA treatment ... Release from blast cells ... Imaging: CXR- pulmonary ... diagnosis #management #hematology ... #oncology
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
ecchymoses, mucosal bleeding ... number of CD34+ cells ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... #hematology #diagnosis
Myelodysplastic Syndromes (MDS) What? Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
unusual bruising or bleeding ... are caused by bleeding ... factor (GCSF) treatments ... Syndromes #diagnosis #hematology ... #oncology
No results found for "bleeding lellis pulmonary treatment hematology cardiology oncology activetb vte"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #bleeding #lellis #pulmonary #treatment #hematology #cardiology #oncology #activetb #vte